GEMCITABINE (GEMZAR) AS A SALVAGE THERAPY AT RELAPSED AND REFRACTORY HODGKIN'S LYMPHOMA

被引:0
|
作者
Violeta, V. [1 ]
Jankovic, S. [1 ]
Andjelic, B. [1 ]
Bogunovic, M. [1 ]
Petrovic, M. [1 ]
Mihaljevic, B. [1 ]
机构
[1] Clin Ctr Serbia, Belgrade, Serbia
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1658
引用
收藏
页码:637 / 637
页数:1
相关论文
共 50 条
  • [41] Outcome of gemcitabine-based salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma
    Kuruvilla, J.
    Nagy, T.
    Zadeh, S.
    Puig, N.
    Seshadri, T.
    Tsang, R.
    Keating, A.
    Crump, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 77 - 77
  • [42] Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT
    Suyani, Elif
    Sucak, Gulsan Turkoz
    Aki, Sahika Zeynep
    Yegin, Zeynep Arzu
    Ozkurt, Zubeyde Nur
    Yagci, Munci
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (06) : 685 - 691
  • [43] FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
    Child, JA
    Johnson, SA
    Rule, S
    Smith, GM
    Morgan, GJ
    Johnson, PWM
    Prentice, AG
    Tollerfield, SM
    Wareham, E
    [J]. LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 309 - 317
  • [44] Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease
    Aurer, I
    Radman, I
    Nemet, D
    Zupancic-Salek, S
    Bogdanic, V
    Mrsic, M
    Sertic, D
    Labar, B
    [J]. ONKOLOGIE, 2005, 28 (11): : 567 - 571
  • [45] Nivolumab therapy for refractory and relapsed Hodgkin's lymphoma - case report
    Macioch, Marta
    Centkowski, Piotr
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (04): : 232 - 236
  • [46] Cyclophosphamide, Gemcitabine, Vinorelbine and Prednisone (CGEV) As Salvage Therapy for Relapsed or Refractory Hodgkin's Lymphoma before Hematopoietic Stem Cell Transplantation: A Single Center Experience
    Cardenas-Araujo, Daniela
    Judith Gonzalez-Leal, Xitlaly
    Gomez-Almaguer, David
    [J]. BLOOD, 2015, 126 (23)
  • [47] A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
    Cohen, Jonathon B.
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    [J]. BLOOD, 2015, 126 (23)
  • [48] Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma
    Moccia, Alden A.
    Hitz, Felicitas
    Hoskins, Paul
    Klasa, Richard
    Power, Maryse M.
    Savage, Kerry J.
    Shenkier, Tamara
    Shepherd, John D.
    Slack, Graham W.
    Song, Kevin W.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 324 - 332
  • [49] ASHAP: AN EFFECTIVE SALVAGE THERAPY FOR REFRACTORY HODGKIN LYMPHOMA
    Cakir, F. B.
    Ozulker, T.
    Ozturk, G.
    [J]. PEDIATRIC BLOOD & CANCER, 2011, 56 (05) : 890 - 890
  • [50] Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children
    Jaffray, Marie
    Buchbinder, Nimrod
    Lutun, Anne
    Schneider, Pascale
    Piquenot, Jean-Michel
    Vannier, Jean-Pierre
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (08) : 1401 - 1406